{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:07:13Z","timestamp":1778152033275,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1999,2,1]],"date-time":"1999-02-01T00:00:00Z","timestamp":917827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,2,1]],"date-time":"1999-02-01T00:00:00Z","timestamp":917827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1999,2]]},"DOI":"10.1023\/a:1006223100561","type":"journal-article","created":{"date-parts":[[2002,12,21]],"date-time":"2002-12-21T20:20:41Z","timestamp":1040502041000},"page":"63-72","source":"Crossref","is-referenced-by-count":25,"title":["Phase I clinical and pharmacokinetic study of an one-hour infusion of ormaplatin (NSC 363812)"],"prefix":"10.1007","volume":"17","author":[{"given":"Kendra D.","family":"Tutsch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhoda Z.","family":"Arzoomanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dona","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary B.","family":"Tombes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Feierabend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Ian","family":"Robins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Spriggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Wilding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"234560_CR1","first-page":"465","volume-title":"Cancer Chemotherapy Principles and Practice","author":"E Reed","year":"1990","unstructured":"Reed E, Kohn KW: Platinum analogues. In: Chabner BA, Collins JM (eds) Cancer Chemotherapy Principles and Practice. JB Lippincott Co, Philadelphia, 1990, pp 465\u2013490"},{"key":"234560_CR2","doi-asserted-by":"crossref","first-page":"704","DOI":"10.7326\/0003-4819-100-5-704","volume":"100","author":"PJ Loehrer","year":"1984","unstructured":"Loehrer PJ, Einhorn LH: Drugs five years later: Cisplatin. Ann Intern Med 100: 704\u2013713, 1984","journal-title":"Ann Intern Med"},{"key":"234560_CR3","first-page":"720","volume":"19","author":"MC Christian","year":"1992","unstructured":"Christian MC: The current status of new platinum analogs. Seminars in Oncol 19: 720\u2013733, 1992","journal-title":"Seminars in Oncol"},{"key":"234560_CR4","first-page":"146","volume":"74","author":"JH Burchenal","year":"1980","unstructured":"Burchenal JH, Irani G, Kern K, Lokys L, Turkevich J: 1-2 diaminocyclohexane platinum derivatives of potential clinical value. Cancer Res 74: 146\u2013155, 1980","journal-title":"Cancer Res"},{"key":"234560_CR5","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1016\/0006-2952(87)90581-8","volume":"36","author":"A Eastman","year":"1987","unstructured":"Eastman A: Glutathione-mediated activation of anticancer platinum (IV) complexes. Biochem Pharmacol 36: 4177\u20134178, 1987","journal-title":"Biochem Pharmacol"},{"key":"234560_CR6","first-page":"997","volume":"70","author":"WK Anderson","year":"1986","unstructured":"Anderson WK, Quafliato DA, Haugwitz RD, Narayanan VL, Wolpert-DeFilippes MK: Synthesis, physical properties and antitumor activity of tetraplatin and related tetrachloroplatinum (IV) stereoisomers of 1,2-diaminocyclohexane. Cancer Treat Rep 70: 997\u20131002, 1986","journal-title":"Cancer Treat Rep"},{"key":"234560_CR7","first-page":"1402","volume":"49","author":"GR Gibbons","year":"1989","unstructured":"Gibbons GR, Wyrick S, Chaney SG: Rapid reduction of tetrachloro (DL-trans)-1,2-diaminocyclohexaneplatinum (IV) (tetraplatin) in RPMI 1640 tissue culture medium. Cancer Res 49: 1402\u20131407, 1989","journal-title":"Cancer Res"},{"key":"234560_CR8","first-page":"1745","volume":"48","author":"A Rahman","year":"1988","unstructured":"Rahman A, Roh JK, Wolpert-DeFilippes MK, Goldin A, Venditti JM, Woolley PV: Therapeutic and pharmacological studies of tetrachloro(d,1-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin), a new platinum analogue. Cancer Res 48: 1745\u20131752, 1988","journal-title":"Cancer Res"},{"key":"234560_CR9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0272-0590(88)90250-3","volume":"10","author":"JH Smith","year":"1988","unstructured":"Smith JH, Smith MA, Litterst CL, Copley MP, Uozumi J, Boyd MR: Comparative toxicity and renal distribution of the platinum analogs tetraplatin, CHIP and cisplatin at equimolar doses in the Fisher 344-rat. Fund Appl Toxicol 10: 45\u201361, 1988","journal-title":"Fund Appl Toxicol"},{"key":"234560_CR10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0272-0590(88)90251-5","volume":"10","author":"MA Smith","year":"1988","unstructured":"Smith MA, Smith JH, Litterst CL, Copley MP, Uozumi J, Boyd MR: In vivo biochemical indices of nephrotoxicity of the platinum analogs tetraplatin, CHIP and cisplatin in the Fisher 344 rat. Fund Appl Toxicol 10: 62\u201372, 1988","journal-title":"Fund Appl Toxicol"},{"key":"234560_CR11","first-page":"291","volume":"27","author":"RA McPherson","year":"1986","unstructured":"McPherson RA, Roh JK, Komanduri K, Mhatre R, Wooley PV, Rahman A: Toxicological evaluation of tetraplatin (NSC 363812) in comparison to CDDP. Proc Am Assoc Cancer Res 27: 291, 1986","journal-title":"Proc Am Assoc Cancer Res"},{"key":"234560_CR12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/1097-0142(19850201)55:3<527::AID-CNCR2820550310>3.0.CO;2-2","volume":"55","author":"MG Kris","year":"1985","unstructured":"Kris MG, Gralla RJ, Tyson LB, Clark RA, Kelsen DP, Reilly LK, Groshen S, Bosl GJ, Kalman LA: Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamthasone, and diphenhydramine. Cancer 55: 527\u2013534, 1985","journal-title":"Cancer"},{"key":"234560_CR13","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1200\/JCO.1993.11.9.1787","volume":"111","author":"HI Robins","year":"1993","unstructured":"Robins HI, Cohen JD, Schmitt CL, Tutsch KD, Feierabend C, Arzoomanian RZ, Alberti D, d'Oleire F, Longo W, Heiss C, Rushing D, Love R, Spriggs D: Phase I clinical trial of carboplatin and 41.8 _C whole-body hyperthermia in cancer patients. J Clin Oncol 111: 1787\u20131794, 1993","journal-title":"J Clin Oncol"},{"key":"234560_CR14","first-page":"5","volume":"14","author":"H Akaike","year":"1976","unstructured":"Akaike H: An information criterion (AIC). Math Sci 14: 5\u20139, 1976","journal-title":"Math Sci"},{"key":"234560_CR15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1201\/b14095","volume-title":"Pharmacokinetics","author":"M Gibaldi","year":"1982","unstructured":"Gibaldi M, Perrier D: Pharmacokinetics, 2nd Edition. Marcel Dekker Inc, New York, 1982, pp 45\u2013111","edition":"2nd Edition"},{"key":"234560_CR16","first-page":"5432","volume":"44","author":"MJ Egorin","year":"1984","unstructured":"Egorin MJ, VanEcho DA, Tipping SJ, Olman EA, Whitacre MY, Thompson BW, Aisner J: Pharmacokinetics and dosage reduction of cis-diammine (1,1cyclobutanedicarboxylato) platinum in patients with impaired renal function. Cancer Res 44: 5432\u20135438, 1984","journal-title":"Cancer Res"},{"key":"234560_CR17","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.1989.7.11.1748","volume":"7","author":"AH Calvert","year":"1989","unstructured":"Calvert AH, Newell DR, Gumbrell LA, O'Reilly S, Burnell M, Boxall FE, Siddik ZH, Judson IR, Gore ME, Wiltshaw E: Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 7: 1748\u20131756, 1989","journal-title":"J Clin Oncol"},{"key":"234560_CR18","first-page":"709","volume":"54","author":"RJ Schilder","year":"1994","unstructured":"Schilder RJ, LaCreta FP, Perez RP, Johnson SW, Brennan JM, Rogatko A, Nash S, McAleer C, Hamilton TC, Roby D, Young RC, Ozols RF, O'Dwyer PJ: Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 schedule. Cancer Res 54: 709\u2013717, 1994","journal-title":"Cancer Res"},{"key":"234560_CR19","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/00001813-199410000-00002","volume":"5","author":"TJ O'Rourke","year":"1994","unstructured":"O'Rourke TJ, Weiss GR, New P, Burris HA, Rodriguez G, Eckhardt J, Hardy J, Kuhn JG, Fields S, Clark GM, Von Hoff DD: Phase I clinical trial of ormaplatin (tetraplatin, NSC 363812). Anti-Cancer Drugs 5: 520\u2013526, 1994","journal-title":"Anti-Cancer Drugs"},{"key":"234560_CR20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/(SICI)1099-081X(199705)18:4<347::AID-BDD23>3.0.CO;2-O","volume":"18","author":"WD Figg","year":"1997","unstructured":"Figg WD, Christian MC, Lush R, Link CJ, Davis P, Kohn E, Sarosy G, Rothenberg ML, Weiss RB, Ryan N, Jacobs J, Reed E: Pharmacokinetics of elemental platinum (ultrafiltrate and total) after a thirty-minute intravenous infusion of ormaplatin. Biopharm Drug Disp 18: 347\u2013359, 1997","journal-title":"Biopharm Drug Disp"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006223100561.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1006223100561\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006223100561.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T19:57:18Z","timestamp":1753819038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1006223100561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,2]]}},"alternative-id":["234560"],"URL":"https:\/\/doi.org\/10.1023\/a:1006223100561","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,2]]}}}